AI English summary of an SEC filing — figures as filed
Universal Health Services UHSThe company said UHS net income attributable to UHS for Q2 2025 rose to $353.2 million ($5.43 per diluted share) from $289.2 million ($4.26 per share) a year earlier, and net revenues increased by 9.6% to $4.284 billion.
Key points
AI summaryThe company said UHS net income attributable to UHS for Q2 2025 rose to $353.2 million ($5.43 per diluted share) from $289.2 million ($4.26 per share) a year earlier, and net revenues increased by 9.6% to $4.284 billion.
The company said its results for Q2 included approximately $101 million in aggregate pre-tax incremental reimbursements, net of related provider taxes, and a pre-tax loss of approximately $25 million at the 142-bed acute care hospital in Washington, D.C., which was completed and opened in April 2025.
The company said net cash provided by operating activities for the first six months of 2025 was $909 million, down from $1.076 billion a year earlier, and that as of June 30, 2025, it had $1.3 billion of aggregate available borrowing capacity under its $1.08 billion revolving credit facility, net of outstanding borrowings and letters of credit.
The company said it raised its full-year 2025 Adjusted EPS-diluted outlook to $20.00 to $21.00 from $18.45 to $19.95, and its Adjusted EBITDA net of NCI outlook to $2.458 billion to $2.543 billion from $2.357 billion to $2.484 billion.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.
UHS Q2 Net Income and Revenue Rise
The company said UHS net income attributable to UHS for Q2 2025 rose to $353.2 million ($5.43 per diluted share) from $289.2 million ($4.26 per share) a year earlier, and net revenues increased by 9.6% to $4.284 billion.
Source · Based on the filing body and exhibits
Medicaid add-on reimbursements and Washington, D.C. hospital loss in Q2
The company said its results for Q2 included approximately $101 million in aggregate pre-tax incremental reimbursements, net of related provider taxes, and a pre-tax loss of approximately $25 million at the 142-bed acute care hospital in Washington, D.C., which was completed and opened in April 2025.
Source · Based on the filing body and exhibits
First-Half Operating Cash Flow Falls; Borrowing Capacity Remains
The company said net cash provided by operating activities for the first six months of 2025 was $909 million, down from $1.076 billion a year earlier, and that as of June 30, 2025, it had $1.3 billion of aggregate available borrowing capacity under its $1.08 billion revolving credit facility, net of outstanding borrowings and letters of credit.
Source · Based on the filing body and exhibits
UHS Raises Full-Year 2025 Outlook
The company said it raised its full-year 2025 Adjusted EPS-diluted outlook to $20.00 to $21.00 from $18.45 to $19.95, and its Adjusted EBITDA net of NCI outlook to $2.458 billion to $2.543 billion from $2.357 billion to $2.484 billion.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…